HomeOpen Access NewsAlzheimer's Disease

Alzheimer's Disease

Alzheimer’s Disease is the most common cause of dementia. Dementia describing a specific set of symptoms such as memory loss, difficulties with problem-solving, language or simply thinking. As the disease progresses, proteins build up in the brain to form structures called ‘plaques’. Eventually there is a break between the nerve cells resulting the death of the cells and a loss of brain tissue. ending in a lack of motor skills. Although progression can vary, typically after diagnosis life expectancy is around three to nine years. Fewer than 3% of people live more than fourteen years.

Management

Medications, psychological intervention and care-giving are all available to AD patients. there are currently 5 different medications on offer for AD each have different results and side affects.

Subscribe to Updates

Dementia in Europe to soar 64% by 2050, Alzheimer’s report warns

Diseases & Conditions
Alzheimer Europe forecasts dementia in Europe to rise 64% by 2050, highlighting urgent health and policy needs.

UCL researchers test finger-prick blood test to diagnose Alzheimer’s

Diseases & Conditions
UCL and partners are testing a simple finger-prick blood test to detect Alzheimer’s disease before symptoms.

Higher blood sugar spikes linked to increased Alzheimer’s risk, Liverpool study finds

Diseases & Conditions
A University of Liverpool study finds people with higher post‑meal blood sugar have a significantly greater risk of developing Alzheimer’s disease.

New European initiative aims to speed up Alzheimer’s diagnosis and treatment

Diseases & Conditions
A new European initiative, in partnership with King’s College London, aims to accelerate earlier diagnosis and improve access to treatment for people living with Alzheimer’s disease.

Nearly 90% of Alzheimer’s cases linked to a single gene

Diseases & Conditions
Large-scale UK Biobank research suggests that variations in the APOE gene, linked to up to 90% of Alzheimer’s cases.

Breakthrough Alzheimer’s test using finger-prick blood samples

Pharma
New finger-prick blood test accurately detects Alzheimer’s biomarkers, enabling at-home collection and broader research.

Weight-loss drug liraglutide may slow Alzheimer’s decline, new study suggests

Diseases & Conditions
New trial finds liraglutide reduces brain shrinkage by nearly 50% in Alzheimer’s patients and slows cognitive decline by up to 18% within a year.

New tool predicts Alzheimer’s risk years before symptoms

Diseases & Conditions
Researchers at Mayo Clinic have created a new prediction model combining age, sex, genetic markers, and brain amyloid levels to estimate an individual's lifetime risk of Alzheimer's or mild cognitive impairment,

Faster MRI scans could make early dementia diagnosis more accessible

Diseases & Conditions
Researchers at UCL have developed a method to reduce MRI scan times for dementia diagnosis by two-thirds, potentially doubling daily scan capacity and improving access to early care.

Nanomedicine breakthrough: Nanoparticles reverse Alzheimer’s pathology in mice

Diseases & Conditions
A UCL-led study shows bioactive nanoparticles can restore blood-brain barrier function and clear amyloid-β in mice, reversing Alzheimer's-like brain changes.

AI-powered blood test detects Alzheimer’s early

Diseases & Conditions
The University of Liverpool researchers create a low-cost, handheld AI-powered blood test to detect Alzheimer's biomarkers, enabling earlier diagnosis and global accessibility.

European perspectives on dementia prevention: Can lifestyle changes reduce risk?

Diseases & Conditions
Although age is a risk factor, there are other modifiable factors that can influence dementia risk and disease progression. Angela Bradshaw, the Director for Research at Alzheimer Europe, emphasises the need for more comprehensive interventions across multiple areas to support dementia prevention

UK launches breakthrough Alzheimer’s blood test trial for NHS use

Pharma
A groundbreaking UK clinical trial led by UCL aims to revolutionise Alzheimer's diagnosis using a simple blood test.

One in five people with dementia receive no support, Alzheimer’s Society finds

Diseases & Conditions
A new Alzheimer's Society survey reveals that one in five people affected by dementia in the UK receive no health, social, or financial support.

Mediterranean diet reduces genetic Alzheimer’s risk, Harvard study finds

Diseases & Conditions
A Harvard study finds that following a Mediterranean diet can lower dementia risk for those with high genetic susceptibility, including APOE4 carriers.

FDA clears first blood test for Alzheimer’s diagnosis

Diseases & Conditions
FDA clearance of the first Alzheimer's blood test marks a significant step toward earlier, more straightforward diagnosis—potentially improving care for adults with memory concerns.

Dementia takes 3.5 years to diagnose after symptoms begin

Diseases & Conditions
A UCL-led study finds dementia diagnoses are delayed by an average of 3.5 years after symptoms appear, with even longer waits for early-onset cases.
123...11Page 1 of 11

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders

Visit Article Archive
Open Access Government

Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.

Follow Us

Resources

Quick Links

Legal & Marketing

As a Crossref Sponsored Member we are able to connect your content with a global network of online scholarly research, currently over 20,000 other organizational members from 160 countries. Crossref drive metadata exchange and support nearly 2 billion monthly API queries, facilitating global research communication.

© Adjacent Digital Politics Ltd